Stay updated on Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page
- ChecktodayChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new cancer types and a revision of the study version, while extensive details about the study's objectives and treatment protocols have been removed.SummaryDifference48%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
Stay in the know with updates to Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.